Dallas, TX -- (SBWIRE) -- 10/31/2013 -- The demand for interventional medical core products has increased continuously with the improvement of living quality and the coming of aging society; PCI (percutaneous coronary intervention) surgical cases also increased year by year. In 2012, the usage quantity of coronary stent was about 633,600 sets and the market scale reached CNY 3.15 billion in China.
The overall market share of domestic brands decreased to 65% in 2012 from 70% in 2011. However, the landscape of Top 3 enterprises was not changed; MicroPort still occupied the leading position with 23% market shares, following by LePu and Shandong JW with 21% and 20% market shares respectively.
In 2012, the major foreign brands Boston Scientific, Medtronic and Abbott strengthened the marketing efforts, and the market share of the three brands reached about 33% in China.
Huidian Research takes a view that, from the aspects of market scale, the annual growth rate of stent system will remain 8% globally on the whole. At present, cardiac interventional surgeries in some developed countries, such as Europe, America, Japan, are comparative mature, so the annual growth rate will continue to remain 3%-5%. While the stent system market of emerging countries represented by China, the annual growth rate will remain 10%-15% in the next five years, the usage quantity (sale volume) of stent system will reach 1.299 million sets.
Explore complete report @ http://www.marketreportschina.com/research-on-china-coronary-stent-industry-2013-2017.
Major points from Table of Contents :
7. Key Enterprises in Coronary Stent Industry
7.1 Boston Scientific
7.1.1 Company Profile
7.1.2 Business Performance
7.1.4 Development Strategy
7.2.1 Company Profile
7.2.2 Business Performance
7.2.3 Mergers and Acquisitions
7.2.4 Development Strategy
7.3.1 Company Profile
7.3.2 Business Performance
7.3.4 Channel Development Strategy
7.4.1 Company Profile
7.4.2 Business Performance
7.4.4 Development Strategy
7.5 Lepu Medical
7.5.1 Company Profile
7.5.2 Business Performance
7.5.3 Main Business
7.5.5 Development Strategy
7.6 JW Medical Systems
7.6.1 Company Profile
7.6.2 Product Advantage
7.6.3 Business Performance
7.6.4 Scientific Research Status
7.6.5 Development Planning
Place a direct purchase order @ http://www.marketreportschina.com/contacts/purchase?rname=3463.
Browse other reports of Life Science category @ http://www.marketreportschina.com/category/life-sciences.
Contact firstname.lastname@example.org for more details.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)